Economic Impact of Adverse Drug Events – A Retrospective Population-Based Cohort Study of 4970 Adults

• Hanna Gyllensten ,

  * E-mail: hanna.gyllensten@nhv.se

  Affiliations Nordic School of Public Health NHV, Gothenburg, Sweden, Section of Social Medicine, Department of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Katja M. Hakkarainen,

  Affiliations Nordic School of Public Health NHV, Gothenburg, Sweden, Section of Social Medicine, Department of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Staffan Hägg,

  Affiliations Department of Drug Research/Clinical Pharmacology, Faculty of Health Sciences, Linköping University, Linköping, Sweden, Futurum – Academy for Health and Care, Jönköping County Council, Jönköping, Sweden

  ⨯
• Anders Carlsten,

  Affiliations Nordic School of Public Health NHV, Gothenburg, Sweden, Medical Products Agency, Uppsala, Sweden

  ⨯
• Max Petzold,

  Affiliation Akademistatistik – Centre for Applied Biostatistics, Occupational and Environmental Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Clas Rehnberg,

  Affiliation Department of Learning, Informatics, Management and Ethics – LIME, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Anna K. Jönsson

  Affiliations Department of Drug Research/Clinical Pharmacology, Faculty of Health Sciences, Linköping University, Linköping, Sweden, Department of Clinical Pharmacology, County Council of Östergötland, Linköping, Sweden

  ⨯